Yuki Kageyama to Immunoconjugates
This is a "connection" page, showing publications Yuki Kageyama has written about Immunoconjugates.
Connection Strength
0.357
-
Successful treatment of primary bone marrow Hodgkin lymphoma with brentuximab vedotin: a case report and review of the literature. J Med Case Rep. 2018 May 30; 12(1):151.
Score: 0.150
-
Time course of gene expression after the injection of adenoviral vectors containing CTLA4IG gene. Transplant Proc. 2004 Oct; 36(8):2443-5.
Score: 0.058
-
Prolonged graft survival induced by CTLA4IG gene transfection in rat lung allografting. Transplant Proc. 2003 Feb; 35(1):456-7.
Score: 0.052
-
CTLA4Ig-gene transfection with FTY720 administration markedly inhibits the obliterative airway disease in heterotopically transplanted rat tracheas. Transplant Proc. 2003 Feb; 35(1):458-60.
Score: 0.052
-
Adenoviral vectors containing the CTLA4IG-gene inhibit chronic rejection in heterotopically transplanted rat tracheas. Transplant Proc. 2000 Nov; 32(7):2036-7.
Score: 0.044